Samhar Al‐Akash

Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome

Larry A. Greenbaum, Marc Fila, Gianluigi Ardissino et al. · Kidney International · 2016 · 286 citations · Full text

Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation

Samhar Al‐Akash, P. Stephen Almond, Van H. Savell et al. · Pediatric Nephrology · 2010 · 95 citations

Translational Medicine, Transplantation, Long-term Remission +7

COVID-19 in children treated with immunosuppressive medication for kidney diseases

Matko Marlais, Tanja Wlodkowski, Samhar Al‐Akash et al. · Archives of Disease in Childhood · 2020 · 61 citations · Full text

Implementation of standardized follow-up care significantly reduces peritonitis in children on chronic peritoneal dialysis

Alicia M. Neu, Troy Richardson, John Lawlor et al. · Kidney International · 2016 · 58 citations

Hemodialysis, Medicine, Dialysis +8

Intravenous immunoglobulin therapy in the treatment of BK viremia and nephropathy in pediatric renal transplant recipients

Elizabeth Anyaegbu, P. Stephen Almond, T. Milligan et al. · Pediatric Transplantation · 2010 · 55 citations